Sharon C Yates1, Nicolaas E Groeneboom1, Christopher Coello1, Stefan F Lichtenthaler2,3,4, Peer-Hendrik Kuhn5, Hans-Ulrich Demuth6, Maike Hartlage-Rübsamen7, Steffen Roßner7, Trygve Leergaard1, Anna Kreshuk8, Maja A Puchades1, Jan G Bjaalie1. 1. Neural Systems Laboratory, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway. 2. German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. 3. Neuroproteomics, School of Medicine, Klinikum rechts der Isar, and Institute for Advanced Study, Technical University of Munich, Munich, Germany. 4. Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. 5. Institute of Pathology, Technical University of Munich, Munich, Germany. 6. Department of Molecular Drug Design and Target Validation Fraunhofer Institute for Cell Therapy and Immunology, Halle (Saale), Leipzig, Germany. 7. Paul Flechsig Institute for Brain Research, University of Leipzig, Leipzig, Germany. 8. European Molecular Biology Laboratory, Heidelberg, Germany.
Abstract
Transgenic animal models are invaluable research tools for elucidating the pathways and mechanisms involved in the development of neurodegenerative diseases. Mechanistic clues can be revealed by applying labelling techniques such as immunohistochemistry or in situ hybridisation to brain tissue sections. Precision in both assigning anatomical location to the sections and quantifying labelled features is crucial for output validity, with a stereological approach or image-based feature extraction typically used. However, both approaches are restricted by the need to manually delineate anatomical regions. To circumvent this limitation, we present the QUINT workflow for quantification and spatial analysis of labelling in series of rodent brain section images based on available 3D reference atlases. The workflow is semi-automated, combining three open source software that can be operated without scripting knowledge, making it accessible to most researchers. As an example, a brain region-specific quantification of amyloid plaques across whole transgenic Tg2576 mouse brain series, immunohistochemically labelled for three amyloid-related antigens is demonstrated. First, the whole brain image series were registered to the Allen Mouse Brain Atlas to produce customised atlas maps adapted to match the cutting plan and proportions of the sections (QuickNII software). Second, the labelling was segmented from the original images by the Random Forest Algorithm for supervised classification (ilastik software). Finally, the segmented images and atlas maps were used to generate plaque quantifications for each region in the reference atlas (Nutil software). The method yielded comparable results to manual delineations and to the output of a stereological method. While the use case demonstrates the QUINT workflow for quantification of amyloid plaques only, the workflow is suited to all mouse or rat brain series with labelling that is visually distinct from the background, for example for the quantification of cells or labelled proteins.
Transgenic animal models are invaluable research tools for elucidating the pathways and mechanisms involved in the development of neurodegenerative diseases. Mechanistic clues can be revealed by applying labelling techniques such as immunohistochemistry or in situ hybridisation to brain tissue sections. Precision in both assigning anatomical location to the sections and quantifying labelled features is crucial for output validity, with a stereological approach or image-based feature extraction typically used. However, both approaches are restricted by the need to manually delineate anatomical regions. To circumvent this limitation, we present the QUINT workflow for quantification and spatial analysis of labelling in series of rodent brain section images based on available 3D reference atlases. The workflow is semi-automated, combining three open source software that can be operated without scripting knowledge, making it accessible to most researchers. As an example, a brain region-specific quantification of amyloid plaques across whole transgenic Tg2576 mouse brain series, immunohistochemically labelled for three amyloid-related antigens is demonstrated. First, the whole brain image series were registered to the Allen Mouse Brain Atlas to produce customised atlas maps adapted to match the cutting plan and proportions of the sections (QuickNII software). Second, the labelling was segmented from the original images by the Random Forest Algorithm for supervised classification (ilastik software). Finally, the segmented images and atlas maps were used to generate plaque quantifications for each region in the reference atlas (Nutil software). The method yielded comparable results to manual delineations and to the output of a stereological method. While the use case demonstrates the QUINT workflow for quantification of amyloid plaques only, the workflow is suited to all mouse or rat brain series with labelling that is visually distinct from the background, for example for the quantification of cells or labelled proteins.
Transgenic rodent models are useful tools in the study of neurodegenerative disorders, providing clues to the origins and mechanisms of the protein aggregates that accumulate and harm neurons and synapses in these conditions (Dawson et al., 2018). A common study approach is to section the brains and apply immunohistochemical or other histological techniques to reveal features that can be explored by microscopy. Qualitative assessments of such features can reveal vulnerable brain regions, while understanding the connectivity of affected regions may provide insight into disease mechanisms (Thal et al., 2002; Hurtado et al., 2010). The ability to accurately assign anatomical location to the data is of crucial importance to the validity of the conclusions drawn, and is a limiting factor in these studies. Present resources for assigning anatomical location to whole brain rodent data are not easily applicable to 2D histological series, especially if cutting angles deviate even marginally from the coronal, sagittal or horizontal planes. Even with diligent sectioning, small deviations of a few degrees are common. Our recent registration tool, QuickNII, allows users to perform that correction (Puchades et al., 2019). For users with coding expertise, other tools for registration of image series to reference atlases are also available (Kopec et al., 2011; Fürth et al., 2018; Xiong et al., 2018). Furthermore, combining datasets from different sources or comparison of data from different animal models is difficult unless the data are linked to the same atlas reference system (Simmons and Swanson, 2009; Kim et al., 2017; Bjerke et al., 2018).The gold standard for quantification of features in 2D image series is stereological analysis applied to anatomical regions that have been manually delineated by an expert in the field (Schmitz and Hof, 2005). However, in practical terms, this method is difficult to apply optimally due to a shortage of anatomical expertise, the significant numbers of sections for analysis, and limited availability of time. Large scale projects and multi-centre collaborations would benefit from the automation of both the extraction and spatial analysis steps. The introduction of the machine learning concept has opened up possibilities for semi-automated extraction of features based on supervised machine learning algorithms (Berg et al., 2019). Furthermore, the new generation of three-dimensional digital brain atlases developed for murine brains (Lein et al., 2007; Hawrylycz et al., 2011; Oh et al., 2014; Papp et al., 2014; Kjonigsen et al., 2015) serve as spatial frameworks for data sharing and integration (Boline et al., 2008; Zaslavsky et al., 2014), while also providing possibilities for automation of spatial analysis.To this end, we have developed the QUINT workflow based on image analysis using a series of neuroinformatic tools. The workflow entails three steps. In the first step, images are registered to a 3D reference atlas. This step utilises a three-dimensional brain atlasing tool, QuickNII (Puchades et al., 2019) that supports arbitrary cutting angles, and is used to generate atlas maps that are customised specifically to match each section. In the second step, segmentation of distinct features such as labelled cells or aggregates is performed with ilastik. The ilastik software benefits from a supervised machine learning approach (Berg et al., 2019) allowing a combination of many parameters for segmentation as is demonstrated in the use cases here. However, the workflow is compatible with segmentations produced by other means, such as NIH ImageJ (Schneider et al., 2012), or with another image analysis tool provided that it supports segmented image export. As illustrated by Pallast et al. (2019), different types of features may require different segmentation tools. In the third step, the Nutil software draws on the atlas maps and segmentations to quantify segmented objects in relation to the delineated brain regions contained in the atlas. Nutil also extracts the xyz position of the segmented objects for viewing in reference atlas space. As an example, we present the quantification of humanamyloid precursor protein (hAPP) and β-amyloid deposits across a whole mouse brain series immunohistochemically labelled For the human APP N-Terminus (rat monoclonal antibody; Höfling et al., 2016), Aβ (4G8 mouse monoclonal antibody) and pyro-glutamate modified Aβ [pE-Aβ; J8 mouse monoclonal antibody (Hartlage-Rübsamen et al., 2018)]. The results are validated by comparing the workflow output with ground truth data manually segmented with the NIH ImageJ tool (Schneider et al., 2012), and by comparing to stereological counts with the MBF Bioscience Stereo Investigator Area Fraction Fractionator probe. A second example is shared to demonstrate the use of the workflow for quantification of another type of labelling (parvalbumin positive cells in an Allen Mouse Brain series).
Materials and Methods
The workflow for serial brain section image analysis comprises several parts (Figure 1): namely, image pre-processing (Nutil using the Transform feature); registration of images to a reference atlas (QuickNII); segmentation of labelled features (ilastik); and quantification of features per atlas region (Nutil using the Quantifier feature).
Figure 1
Workflow for automated quantification and spatial analysis. Diagram showing key steps of the workflow (blue frames). After sectioning and labelling, brain sections are digitalised. Serial section images are pre-processed, and then registered to a 3-D reference atlas space using the QuickNII tool. The same images are segmented using the ilastik tool. Exported custom atlas maps and segmented images are then combined in the Nutil tool in order to extract quantification of objects in atlas brain regions as well as 3D coordinates of the objects.
Workflow for automated quantification and spatial analysis. Diagram showing key steps of the workflow (blue frames). After sectioning and labelling, brain sections are digitalised. Serial section images are pre-processed, and then registered to a 3-D reference atlas space using the QuickNII tool. The same images are segmented using the ilastik tool. Exported custom atlas maps and segmented images are then combined in the Nutil tool in order to extract quantification of objects in atlas brain regions as well as 3D coordinates of the objects.
Use Case Material: Animal, Immunohistochemical Labelling and Image Acquisition
An 18-month-old male Tg2576 mouse (Hsiao et al., 1996) mimicking the amyloid pathology of Alzheimer’s disease supplied the material for the first use case (plaque quantification). This study was carried out in accordance with the principles of the Basel Declaration and recommendations of the ARRIVE guidelines, National Centre for the Replacement, Refinement and Reduction of Animals in Research, UK. The protocol used was approved by the responsible authority Landesdirektion Sachsen, Germany, license number T28/16. The mouse was sacrificed by CO2 inhalation and the brain was fixed using the transcardial perfusion fixation method. First, the brain was perfused with 30 mL of PBS, followed by 30 mL of 4% paraformaldehyde (PFA) solution and post-fixed at 4°C overnight. The brain was cryoprotected by immersion in 30% sucrose for 3 days and sectioned using a freezing microtome in 30 μm thick coronal sections. Every 4th section (60 sections) was used for immunolabelling of hAPP using the species-specific monoclonal rat antibody 1D1 (dilution 1:2; Höfling et al., 2016). Neighbouring sections with the same sampling frequency were labelled with the 4G8 antibody detecting pan-Aβ (BioLegend RRID:AB_2734548, 1:8,000) and with the J8 antibody detecting pE-Aβ (1:2,000; Hartlage-Rübsamen et al., 2018). After incubation with biotinylated secondary antibodies (1:1,000; Dianova; Hamburg, Germany) in TBS with 2% bovine serum albumin for 60 min at room temperature, the ABC method was applied, which comprised incubation with complexed streptavidin–horseradish peroxidase (1:1,000; Sigma; Deisenhofen, Germany). Incubations were separated by washing steps (3-times, 5 min). Binding of peroxidase was visualised by incubation with 4 mg 3,3′-diaminobenzidine and 2.5 μl H2O2 per 5 ml Tris buffer (0.05 M; pH 7.6) for 1–2 min. Stained brain sections were extensively washed and mounted onto microscope slides. All brain sections were scanned using a Zeiss Axioscan Z1 slide scanner running Zeiss Zen Software (Carl Zeiss MicroImaging, Jena, Germany) with a 20× objective. Images were exported in Tagged Information File Format (TIFF). The background in the raw images was adjusted within the Zen software in order to optimise the signal to noise ratio, with the same parameters for all images, thereby allowing comparative results. The resolution of the exported Tiff images was constant within each series (0.284 μm/pixel for the antibody 1D1 and 0.265 μm/pixel for the antibodies 4G8 and J8).
The Transform feature in the Nutil software enables image rotation, renaming, resizing and mirroring and was used to prepare the image series for QuickNII alignment and ilastik segmentation. Several sets of images were prepared as the input size requirements for the QuickNII and ilastik software differ. For QuickNII, the input requirements are described in Puchades et al. (2019). For ilastik the resizing was performed in order to enable efficient processing and to comply with the pixel scale restriction of the features imposed by the ilastik software. To clarify, the pixel classification algorithm relies on input from manual user annotations of training images, and the features–intensity, edge and/or texture–of the image pixels. The features at different scales are computed as filters with pre-smoothing by a Gaussian with a sigma ranging from 0.3 to 10. For each pixel, the algorithm thus considers the values of the filters in a small sphere around the pixel (the maximal sphere radius is approximately 35 pixels) in the annotated regions, on a scale of 0.3 to 10 pixels. This means that the pixel features must fall within a maximum 10 × 10 pixel window for detection (for example, a repeating textural pattern). The resize factor was selected with reference to this maximum pixel scale to bring the labelled objects within the detection range for all the features, hence achieving a better segmentation (see the ilastik manual for more information). In practise, a test run was performed with ilastik on images of different sizes to find the optimal resolution for segmentation, with a final resize factor of 0.1 selected for the pE-Aβ series, and a factor of 0.05 for the hAPP and pan-Aβ series.The Nutil software is shared through the HBP and is available for download at NITRC with an extensive user manual. See also Github.
Alignment of Sections to Atlas Space With QuickNII
Registration to reference atlas by QuickNII. Following initial preprocessing steps where the sequence and orientation of the serial images is validated and a configuration file generated, images are imported to QuickNII together with a 3-D reference atlas of the mouse brain. In QuickNII, an atlas overlay image which is interactively manipulated to generate an image with position, scale, and orientation (rotation and tilt) that best matches the selected experimental images (DV: +13; ML: −4). QuickNII automatically propagates information about position, scale, and tilt to the entire series. By iterative anchoring of selected key sections, the user can optimize the automatically propagated parameters. The rotation and position of the overlay atlas image is validated and if needed adjusted by the user. Output from QuickNII is a series of custom atlas plates matching each anchored experimental image, and an XML file describing a set of vectors (o, u, and v) that define the position of each image relative to the technical origin of the reference atlas used.
Registration to reference atlas by QuickNII. Following initial preprocessing steps where the sequence and orientation of the serial images is validated and a configuration file generated, images are imported to QuickNII together with a 3-D reference atlas of the mouse brain. In QuickNII, an atlas overlay image which is interactively manipulated to generate an image with position, scale, and orientation (rotation and tilt) that best matches the selected experimental images (DV: +13; ML: −4). QuickNII automatically propagates information about position, scale, and tilt to the entire series. By iterative anchoring of selected key sections, the user can optimize the automatically propagated parameters. The rotation and position of the overlay atlas image is validated and if needed adjusted by the user. Output from QuickNII is a series of custom atlas plates matching each anchored experimental image, and an XML file describing a set of vectors (o, u, and v) that define the position of each image relative to the technical origin of the reference atlas used.Within QuickNII, the volumetric brain reference atlases are used to generate customised atlas maps that match the spatial orientation and proportions of the experimental sections. In the software, the location is defined by superimposing the reference atlas onto the section images in a process termed “anchoring.” In “anchoring” the cutting angle of the reference atlas is adjusted to match the plane of the sections, with the position of each section identified prior to a manual adaptation of each atlas image to match the section images using affine transformations. Anchoring of a series of, e.g., 100 sections from an animal, typically takes 2–6 h, depending on the quality of the sections in the series (distorted sections are more difficult to anchor).The QuickNII software is available at NITRC through the HBP1.
Image Segmentation With Ilastik
The ilastik software was used to segment the downscaled section images for immunohistochemically labelled plaques (60 images per series: hAPP, Aβ and pE-Aβ; Berg et al., 2019; version 1.2.2. post2 for Windows, 64-bit). The segmentation was performed in two steps. First using Pixel Classification to differentiate the immunoreactivity from the background, followed by Object Classification to differentiate the specific immunoreactivity from labelled artefacts (Figure 3). For each image series, only 10% of the images were used to train the classifiers, which were then applied to the whole series in a batch mode, saving considerable time compared to an individual segmentation approach (segmentation of a whole image series takes a few hours depending on the size and number of images).
Figure 3
Segmentation of images with the ilastik software. An image of a Tg2576 mouse brain section, immunohistochemically labelled for pan-Aβ (4G8), processed with the pixel and object classification workflows in the ilastik software (version 1.2.2. post2). Panels (A,C,E,G) show the whole image, with (B,D,F,H) representing the area identified in the dashed box. (C,D) show the output of the pixel classification workflow, with images segmented into five classes based on differences in intensity, edge and texture (red: specific immunohistochemical labelling, blue: unlabelled tissue, purple: artefacts, black: non-specific labelling, yellow: background). The pixel classification workflow is able to differentiate labelling and artefacts such as marks on the coverslip and debris (see arrows). Panels (E,F) show the output of the object classification workflow: the probability maps derived from the pixel classification workflow were thresholded at 0.4 for the channel representing the labelling, and classified into two classes based on object-level features such as size and shape (red: β-amyloid plaques, blue: non-specific labelling). Panels (G,H) show the object classification output with the blue channel removed to visualize the β-amyloid plaques only. Images (A,C,E,G) are displayed at the same magnification with the scale bar representing 1 mm. The scale bar for figures (B,D,F,H) represents 500 μm.
Segmentation of images with the ilastik software. An image of a Tg2576 mouse brain section, immunohistochemically labelled for pan-Aβ (4G8), processed with the pixel and object classification workflows in the ilastik software (version 1.2.2. post2). Panels (A,C,E,G) show the whole image, with (B,D,F,H) representing the area identified in the dashed box. (C,D) show the output of the pixel classification workflow, with images segmented into five classes based on differences in intensity, edge and texture (red: specific immunohistochemical labelling, blue: unlabelled tissue, purple: artefacts, black: non-specific labelling, yellow: background). The pixel classification workflow is able to differentiate labelling and artefacts such as marks on the coverslip and debris (see arrows). Panels (E,F) show the output of the object classification workflow: the probability maps derived from the pixel classification workflow were thresholded at 0.4 for the channel representing the labelling, and classified into two classes based on object-level features such as size and shape (red: β-amyloid plaques, blue: non-specific labelling). Panels (G,H) show the object classification output with the blue channel removed to visualize the β-amyloid plaques only. Images (A,C,E,G) are displayed at the same magnification with the scale bar representing 1 mm. The scale bar for figures (B,D,F,H) represents 500 μm.
Ilastik Pixel Classification Workflow
The Pixel Classifiers were trained with the training images selected for each series (approximately every 6th section per series). All the available features (texture, edge, and intensity) and feature scales (0.3–10 pixels) were included in the classification algorithms. In the training phase, annotations were placed on the first training image, a few pixels at a time, with inspection of the predictions with each annotation. To refine the classifier and increase its applicability to the whole series, each training image was annotated in turn until the predictions were of a good standard across all the training images. The trained classifier was then applied to the series in the batch mode, with probability maps exported for the whole series.
Ilastik Object Classification Workflow
The object classifier differentiates objects based on features such as size and shape, and was applied to the output of the pixel classification to remove artefacts that could not be removed by pixel classification alone (for example, the elongated immunoreactivity around the edges of sections as opposed to the typically circular plaques). The training approach was the same as for the pixel classification, with the same subset of training images used. The probability maps were thresholded at a probability of 0.4 for all the series, with the object size filters set to 8–10,00,000 pixels for the hAPP and pE-Aβ series, and 4–10,00,000 pixels for the pan-Aβ series (the pan-Aβ labelled objects were smaller than the hAPP and pE-Aβ objects). All the object features in the ilastik software, except the location features, were included in the classifier (find more information on this in the ilastik user manual). The trained classifier was applied to the whole series in the batch mode, with the object prediction maps exported in PNG format. NIH imageJ was then used to apply colours to the predictions maps with the glasbey lookup table, and the coloured versions used as input for Nutil Quantifier.
Quantification of Labelling in the Different Brain Regions With Nutil Quantifier
Once the section images were segmented (ilastik) and registered to the relevant reference atlas (QuickNII), Nutil—a software application developed in-house—was used to extract quantitative data about the labelling in each region in the reference atlas (Quantifier feature).Nutil is a stand-alone application that allows for object classification from arbitrary image input files. The code for Quantifier uses a standard recursive pixel filling algorithm in order to scan for and separate individual objects in a 2D segmented image. This means that for each pixel that is not classified as a background pixel, the algorithm checks whether there are neighbouring pixels that are also not part of the background. If so, Nutil applies the same algorithm to these neighbours, and repeats the process until all surrounding pixels are background only. The cluster of collected pixels is considered to be an object, which is added to a global list of objects before being assigned a label ID that is matched with the corresponding reference atlas. This is performed by selecting the top left pixel from each identified object and using this position as a lookup in the reference atlas image files. In addition, the statistical properties of each cluster are calculated and stored (position, width, height, area, size, et cetera). When the entire batch process has completed, reports are produced, which are based on user inputs such as individual colour assignment for different label IDs, areas to exclude, areas to merge, et cetera. Finally, a set of report files are generated, in addition to customised atlas images superimposed with colour-coded (and labelled) objects.Nutil is available for download at NITRC with an extensive user manual. See also Github. The Nutil
Quantifier feature is fast to run, taking seconds to minutes on a desktop computer depending on the size and number of images for analysis.
Validation of the Image Segmentation
In order to validate the segmentations produced with the ilastik software, their area outputs as determined with Nutil
Quantifier were compared to ground truth measurements obtained by manual delineation of plaques for five sections (s14, s54, s94, s134 and s174), and to stereological measurements on 30 sections (s6, s14, s22, s30, s38, s40, s54, s62, s70, s78, s86, s94, s120, s110, s118, s126, s134, s142, s150, s158, s166, s174, s182, s190, s198, s206, s214, s222, s230, s238). The comparisons were performed on section images that were immunohistochemically labelled for hAPP (1D1 antibody) and restricted to clearly visible plaques (we excluded neuronal hAPP labelling). For both the 5 and 30 section subsets, the sections were regularly spaced and spanned the full volume of the brain. The subsets represented 8% and 50% of the full hAPP series, respectively. The section images that were used to train the classifiers (training images) were not selected for the validation.The ground truth area measurements were obtained for five of the sections by manual delineation of the hAPP immunoreactive plaques by an expert in the field, with the NIH ImageJ tool (Analyse function) on images at 5% of the original size. Immunolabelled plaques were delineated for individual objects at the pixel level. For each image, the surface area occupied by plaques was calculated with reference to the resize factor and the pixel length in the original image.Stereological analysis of hAPP immunoreactivity was performed with the Area Fraction Fractionator probe in the MBF Stereo Investigator software (version 2017.02.2; MBF Bioscience, Chicago, IL, USA) with a sampling grid of 300 μm × 300 μm, a counting frame of 200 μm × 200 μm, and a 20 μm point spacing. The settings were selected with reference to the literature (Tucker et al., 2008; Liu et al., 2017; Wagner et al., 2017). Points within the section contours that overlapped the hAPP immunoreactive plaques were marked as positive; with all remaining points marked as negative. hAPP plaque load was calculated by the software with respect to the magnification. The 30 section subset included the five sections for which ground truth measurements were available, allowing comparison of three methods for the five section subset.
Validation of the Atlas Delineations
To validate the atlas delineations derived from the QuickNII software, we compared the plaque loads for five sections in three anatomical brain regions delineated by two alternative methods. The comparisons were performed on section images that were immunohistochemically labelled for hAPP (1D1 antibody) and restricted to clearly visible plaques (we excluded neuronal hAPP labelling). For the first delineation method, five section images were segmented to extract labelled plaques with the ilastik method. The segmentations were then visualised on top of the original images, and the cortex, olfactory region and hippocampus manually delineated with the NIH ImageJ tool with guidance from the Franklin and Paxinos mouse brain atlas version 3 (Franklin and Paxinos, 2008). The Analyse function in NIH ImageJ was used to quantify hAPP plaques in the delineated regions for each brain section. Brain region-specific hAPP load was calculated by dividing the area occupied by hAPP labelling within the selected brain region by the total area occupied by the brain region. For the second method, the same five segmentations were processed with the QUINT workflow with the delineations derived from the QuickNII atlas maps. The hAPP loads were extracted for the cortex, olfactory region and hippocampus for the five sections from the output reports.
As accurate segmentation of the labelled objects is important for a valid quantitative result, we decided to compare our results with three different methods. The segmentations generated with ilastik were compared to manual delineation of labelled objects by an expert in the field (five sections), and to measurements obtained with a stereological method (30 sections). The hAPP labelled series was selected for the validation. The ilastik segmentations gave hAPP load estimates that were similar to the stereological estimates, and that represented the outputs from manual object delineations for the five sections for which manual object delineations were available (error of ilastik estimates relative to manual object delineations: mean −0.06% with a SD of 0.09%; error of stereological estimate relative to manual object delineations: mean −0.05% with a SD of 0.11%; see Figure 4A).
Figure 4
Comparison of whole section human amyloid precursor protein (hAPP) load outputs from three alternative quantitative methods. For all the methods, the whole section hAPP load was calculated by dividing the area occupied by hAPP labelling by the total section area. Calculations were restricted to plaques that were immuno-labelled with the hAPP antibody (1D1). Panel (A) compares hAPP load outputs from three alternative methods for five sections. The methods include expert manual delineation of hAPP labelled objects (green), stereological estimate with the area fraction fractionator probe (blue), and quantification with NIH ImageJ based on the ilastik segmentations (orange). Panel (B) compares hAPP load outputs from the stereological method and from the segmentations for thirty whole brain sections that were regularly spaced and spanned the full volume of the brain.
Comparison of whole section humanamyloid precursor protein (hAPP) load outputs from three alternative quantitative methods. For all the methods, the whole section hAPP load was calculated by dividing the area occupied by hAPP labelling by the total section area. Calculations were restricted to plaques that were immuno-labelled with the hAPP antibody (1D1). Panel (A) compares hAPP load outputs from three alternative methods for five sections. The methods include expert manual delineation of hAPP labelled objects (green), stereological estimate with the area fraction fractionator probe (blue), and quantification with NIH ImageJ based on the ilastik segmentations (orange). Panel (B) compares hAPP load outputs from the stereological method and from the segmentations for thirty whole brain sections that were regularly spaced and spanned the full volume of the brain.For the 30 sections, the mean error of the hAPP loads from the ilastik method relative to the stereological method was 2.79 × 10−3% with a SD of 0.16% (see Figure 4B). To summarise, this means that for this image series, the ilastik method allows the user to establish the plaque load (restricted to hAPP labelled plaques) with 95% confidence to within an error of ±0.32%. As described in the results, the plaque load variations detected from section to section and between brain regions were of a much greater magnitude than this error, indicating that the ilastik method is suitable for detecting these differences.
Validation of Anatomical Delineations From QuickNII
In a separate study, to validate the accuracy of the atlas delineations from QuickNII, we compared the hAPP loads from the QUINT workflow to loads calculated based on manual delineations of three brain regions for five sections (cortex, olfactory region and hippocampus; Figure 5). The QuickNII delineations gave hAPP loads that were representative of the loads from the manual delineations for all the sections and brain regions that were investigated (Figures 5E–G). Overall, the QUINT workflow slightly underestimated the hAPP loads relative to the manual method for all the explored brain regions (deviation of the workflow derived cortical hAPP load from the manual method: mean of −0.11% with SD of 0.07%; deviation of workflow derived olfactory hAPP load from manual method: mean of −0.21% with SD of 0.23%; mean and SD are not provided for the hippocampus as only two sections contained this region).
Figure 5
Comparison of hAPP load outputs in three anatomical brain regions defined by two alternative anatomical delineation methods. Brain region-specific hAPP load was calculated by dividing the area occupied by hAPP labelling within the selected brain region, by the total area occupied by the brain region. The calculations were restricted to plaques that were immuno-labelled with the hAPP antibody (1D1). For the first method, five brain section images were segmented with ilastik and visualised on top of the sections to allow manual delineation of brain regions. The cortex, olfactory region and hippocampus were delineated with NIH
ImageJ with guidance from the Franklin and Paxinos mouse brain atlas version 3 (panels A,C show the cortex, olfactory region and hippocampus delineated in red, blue and yellow in section s134 and s174 respectively). The analyse function in NIH Image J was used to quantify hAPP load in the delineated regions. For the second method, the five segmentations were processed with the QUINT workflow with input from the QuickNII derived atlas maps (panels B,D show examples for s134 and s174 respectively). hAPP loads were extracted for the cortex, olfactory region and hippocampus from the output reports. Panels (E–G) compare hAPP loads in the cortex, olfactory regions and hippocampus respectively for the five sections, with the loads calculated by the two alternative methods described.
Comparison of hAPP load outputs in three anatomical brain regions defined by two alternative anatomical delineation methods. Brain region-specific hAPP load was calculated by dividing the area occupied by hAPP labelling within the selected brain region, by the total area occupied by the brain region. The calculations were restricted to plaques that were immuno-labelled with the hAPP antibody (1D1). For the first method, five brain section images were segmented with ilastik and visualised on top of the sections to allow manual delineation of brain regions. The cortex, olfactory region and hippocampus were delineated with NIH
ImageJ with guidance from the Franklin and Paxinos mouse brain atlas version 3 (panels A,C show the cortex, olfactory region and hippocampus delineated in red, blue and yellow in section s134 and s174 respectively). The analyse function in NIH Image J was used to quantify hAPP load in the delineated regions. For the second method, the five segmentations were processed with the QUINT workflow with input from the QuickNII derived atlas maps (panels B,D show examples for s134 and s174 respectively). hAPP loads were extracted for the cortex, olfactory region and hippocampus from the output reports. Panels (E–G) compare hAPP loads in the cortex, olfactory regions and hippocampus respectively for the five sections, with the loads calculated by the two alternative methods described.
Whole brain comparative analysis of three series labelled for hAPP, pE-Aβ and pan-Aβ in a Tg 2576 Mouse. Examples of Nutil image output (segmentations superimposed on the atlas maps) for the hAPP (A,D), pan-Aβ (B,E) and pE-Aβ series (C,F). The segmented object colours represent their anatomical location: isocortex (red); hippocampus (yellow); white matter tracts (pink); olfactory regions (blue); caudate putamen (CPu; black). Panel (G) shows the comparative quantification results for the whole brain for the three series (the blue, red and green bars represent hAPP, pan-Aβ and pE-Aβ labelling respectively). The abbreviations in the graph represent the following brain regions: isocortex (Cx); white matter tracts (Wm); hippocampal region (HC); olfactory regions (Olf); hypothalamus (Hyp); CPu; midbrain, hind brain and medulla (MHM); thalamus (Thal). Images (A–C) are displayed at the same magnification with the scale bar representing 1 mm. The scale bar for figures (D–F) represents 500 μm. The asterisk in panel (G) indicates the region represented in Figure 7.
Figure 7
Comparative analysis of hAPP, pE-Aβ and pan-Aβ labelling in the hippocampus of a Tg 2576 mouse. (A) The pie charts show the percentage of the total labelling of hAPP (blue chart), pan-Aβ (red chart) and pE-Aβ (green chart) in the hippocampus expressed in the subiculum (Sub), dentate gyrus (DG), entorhinal cortex (EC), cornu ammonis (CA) and fasciola cinereum (FC; B,C). The expression differences are visualised for the subiculum and the EC with the MeshView atlas viewer (the regions are shown in pale green with the Nutil output from the three series covisualised, with objects labelled for hAPP, pan-Aβ and pE-Aβ in blue, red and dark green respectively). Both the pie charts and the brain images reveal spatial expression differences for the three markers in the hippocampus.
Figure 8
Size distribution of objects labelled for hAPP (A), pan-Aβ (B) and pE-Aβ (C) in a whole T2576 mouse brain series. Object size in μm2 is represented on the x-axis on a common logarithmic scale with frequency on the y-axis. To remove false positive objects, minimum object size cut-offs of 258 μm2, 112 μm2 and 56 μm2 were applied to the hAPP (A), pan-Aβ (B) and pE-Aβ (C) series, respectively.
Whole brain comparative analysis of three series labelled for hAPP, pE-Aβ and pan-Aβ in a Tg 2576 Mouse. Examples of Nutil image output (segmentations superimposed on the atlas maps) for the hAPP (A,D), pan-Aβ (B,E) and pE-Aβ series (C,F). The segmented object colours represent their anatomical location: isocortex (red); hippocampus (yellow); white matter tracts (pink); olfactory regions (blue); caudate putamen (CPu; black). Panel (G) shows the comparative quantification results for the whole brain for the three series (the blue, red and green bars represent hAPP, pan-Aβ and pE-Aβ labelling respectively). The abbreviations in the graph represent the following brain regions: isocortex (Cx); white matter tracts (Wm); hippocampal region (HC); olfactory regions (Olf); hypothalamus (Hyp); CPu; midbrain, hind brain and medulla (MHM); thalamus (Thal). Images (A–C) are displayed at the same magnification with the scale bar representing 1 mm. The scale bar for figures (D–F) represents 500 μm. The asterisk in panel (G) indicates the region represented in Figure 7.Comparative analysis of hAPP, pE-Aβ and pan-Aβ labelling in the hippocampus of a Tg 2576 mouse. (A) The pie charts show the percentage of the total labelling of hAPP (blue chart), pan-Aβ (red chart) and pE-Aβ (green chart) in the hippocampus expressed in the subiculum (Sub), dentate gyrus (DG), entorhinal cortex (EC), cornu ammonis (CA) and fasciola cinereum (FC; B,C). The expression differences are visualised for the subiculum and the EC with the MeshView atlas viewer (the regions are shown in pale green with the Nutil output from the three series covisualised, with objects labelled for hAPP, pan-Aβ and pE-Aβ in blue, red and dark green respectively). Both the pie charts and the brain images reveal spatial expression differences for the three markers in the hippocampus.Size distribution of objects labelled for hAPP (A), pan-Aβ (B) and pE-Aβ (C) in a whole T2576 mouse brain series. Object size in μm2 is represented on the x-axis on a common logarithmic scale with frequency on the y-axis. To remove false positive objects, minimum object size cut-offs of 258 μm2, 112 μm2 and 56 μm2 were applied to the hAPP (A), pan-Aβ (B) and pE-Aβ (C) series, respectively.Our workflow is demonstrated here on brain section images from one animal only, with analysis restricted to hAPP and Aβ plaques. However, the QUINT workflow can also be applied to other types of labelling like cell somas, as demonstrated by the quantification and spatial analysis of parvalbumin positive cells from an Allen mouse brain in situ hybridisation experiment shared through the HBP platform: DOI: 10.25493/6DYS-M3W (Yates and Puchades, 2019).
The datasets generated for this study are available on request to the corresponding author.
Ethics Statement
All experiments were performed according to ethical guidelines (License number T28/16 of the Landesdirektion Sachsen, Germany).
Author Contributions
SY performed ilastik and Nutil analyses, performed the validation studies, contributed to the development of the Nutil software and contributed to writing the article. NG created the Nutil software, contributed to the writing of the technical parts of the article and to the design of the validation studies. CC contributed to the development of workflows and validation studies. SL, P-HK, H-UD, MH-R and SR provided animal tissue and antibodies used in the use-case, and contributed to writing the article. TL contributed to the development of workflows and to writing the article. AK contributed with ilastik software support. MP conceived the study, supervised the analysis and the development of software tools, performed file pre-processing and QuickNII registrations and coordinated the writing of the article. JB conceived the study, supervised development of software tools, contributed with infrastructure, and contributed to writing of the article. All the authors reviewed and approved the manuscript.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Authors: Ed S Lein; Michael J Hawrylycz; Nancy Ao; Mikael Ayres; Amy Bensinger; Amy Bernard; Andrew F Boe; Mark S Boguski; Kevin S Brockway; Emi J Byrnes; Lin Chen; Li Chen; Tsuey-Ming Chen; Mei Chi Chin; Jimmy Chong; Brian E Crook; Aneta Czaplinska; Chinh N Dang; Suvro Datta; Nick R Dee; Aimee L Desaki; Tsega Desta; Ellen Diep; Tim A Dolbeare; Matthew J Donelan; Hong-Wei Dong; Jennifer G Dougherty; Ben J Duncan; Amanda J Ebbert; Gregor Eichele; Lili K Estin; Casey Faber; Benjamin A Facer; Rick Fields; Shanna R Fischer; Tim P Fliss; Cliff Frensley; Sabrina N Gates; Katie J Glattfelder; Kevin R Halverson; Matthew R Hart; John G Hohmann; Maureen P Howell; Darren P Jeung; Rebecca A Johnson; Patrick T Karr; Reena Kawal; Jolene M Kidney; Rachel H Knapik; Chihchau L Kuan; James H Lake; Annabel R Laramee; Kirk D Larsen; Christopher Lau; Tracy A Lemon; Agnes J Liang; Ying Liu; Lon T Luong; Jesse Michaels; Judith J Morgan; Rebecca J Morgan; Marty T Mortrud; Nerick F Mosqueda; Lydia L Ng; Randy Ng; Geralyn J Orta; Caroline C Overly; Tu H Pak; Sheana E Parry; Sayan D Pathak; Owen C Pearson; Ralph B Puchalski; Zackery L Riley; Hannah R Rockett; Stephen A Rowland; Joshua J Royall; Marcos J Ruiz; Nadia R Sarno; Katherine Schaffnit; Nadiya V Shapovalova; Taz Sivisay; Clifford R Slaughterbeck; Simon C Smith; Kimberly A Smith; Bryan I Smith; Andy J Sodt; Nick N Stewart; Kenda-Ruth Stumpf; Susan M Sunkin; Madhavi Sutram; Angelene Tam; Carey D Teemer; Christina Thaller; Carol L Thompson; Lee R Varnam; Axel Visel; Ray M Whitlock; Paul E Wohnoutka; Crissa K Wolkey; Victoria Y Wong; Matthew Wood; Murat B Yaylaoglu; Rob C Young; Brian L Youngstrom; Xu Feng Yuan; Bin Zhang; Theresa A Zwingman; Allan R Jones Journal: Nature Date: 2006-12-06 Impact factor: 49.962
Authors: Ingvild E Bjerke; Martin Øvsthus; Eszter A Papp; Sharon C Yates; Ludovico Silvestri; Julien Fiorilli; Cyriel M A Pennartz; Francesco S Pavone; Maja A Puchades; Trygve B Leergaard; Jan G Bjaalie Journal: Eur Psychiatry Date: 2018-03-05 Impact factor: 5.361
Authors: Yongsoo Kim; Guangyu Robert Yang; Kith Pradhan; Kannan Umadevi Venkataraju; Mihail Bota; Luis Carlos García Del Molino; Greg Fitzgerald; Keerthi Ram; Miao He; Jesse Maurica Levine; Partha Mitra; Z Josh Huang; Xiao-Jing Wang; Pavel Osten Journal: Cell Date: 2017-10-05 Impact factor: 41.582
Authors: Corinna Höfling; Markus Morawski; Ulrike Zeitschel; Elisa R Zanier; Katrin Moschke; Alperen Serdaroglu; Fabio Canneva; Stephan von Hörsten; Maria-Grazia De Simoni; Gianluigi Forloni; Carsten Jäger; Elisabeth Kremmer; Steffen Roßner; Stefan F Lichtenthaler; Peer-Hendrik Kuhn Journal: Aging Cell Date: 2016-07-29 Impact factor: 9.304
Authors: Ingvild E Bjerke; Sharon C Yates; Arthur Laja; Menno P Witter; Maja A Puchades; Jan G Bjaalie; Trygve B Leergaard Journal: iScience Date: 2020-12-08
Authors: Muhammad Rahmad Royan; Khadeeja Siddique; Gergely Csucs; Maja A Puchades; Rasoul Nourizadeh-Lillabadi; Jan G Bjaalie; Christiaan V Henkel; Finn-Arne Weltzien; Romain Fontaine Journal: Front Endocrinol (Lausanne) Date: 2021-08-23 Impact factor: 5.555
Authors: Juan C Sanchez-Arias; Micaël Carrier; Simona D Frederiksen; Olga Shevtsova; Chloe McKee; Emma van der Slagt; Elisa Gonçalves de Andrade; Hai Lam Nguyen; Penelope A Young; Marie-Ève Tremblay; Leigh Anne Swayne Journal: Front Neuroanat Date: 2021-12-06 Impact factor: 3.856